Dr. Glenn recently joined Herspiegel as a Principal on the Market Access Team. She supports innovation and research design employing real-world data assets across all therapeutic areas and is passionate about providing high quality research solutions. She provides oversight of project development, with key expertise in observational research using epidemiologic methods. She has experience managing and analyzing data from a variety of sources including healthcare claims, laboratory, vital statistics, maternal/child health, public health surveillance and survey data. Dr. Glenn’s pan-therapeutic research experience includes oncology, clinicogenomics, diabetes, and cardiovascular disease.

Prior to joining Herspiegel, she worked as the VP of Research Consulting with Optum; served as an epidemiologist with AstraZeneca and Amgen; worked as the Principal Investigator and project director for a CMS hospital quality programs contract; and served as the Director of Healthcare Statistics at a state public health agency. Dr. Glenn earned her bachelor’s degree from James Madison University, her MPH from Georgia State University and her doctorate in epidemiology from Vanderbilt University. She has authored or been a co-author on publications appearing in Public Health Reports, the Journal of Public Health Management and Practice, the Annals of Epidemiology, Archives of Ophthalmology, Frontiers of Public Health, and the Annals of Human Genetics, among others.